Systematic review / meta-analysis / 2007
In children, probiotics significantly reduced antibiotic-associated diarrhea in per-protocol analysis but not in intention-to-treat analysis.
Ten randomized controlled trials assessed probiotics (such as Lactobacilli spp., Bifidobacterium spp., Streptococcus spp., or Saccharomyces boulardii) for preventing antibiotic-associated diarrhea in children. Per-protocol analysis of 9 trials showed a significant reduction in diarrhea favoring probiotics (RR 0.49; 95% CI 0.32 to 0.74), but intention-to-treat analysis was not statistically significant (RR 0.90; 95% CI 0.50 to 1.63). Five trials monitored for adverse events (n = 647) with no serious adverse events reported. The authors concluded that while data are promising, routine recommendation of probiotics for pediatric AAD remains premature.
- Study type
- Systematic review and meta-analysis of RCTs
- Who was studied
- Children aged 0 to 18 years receiving antibiotics (10 studies included)
- What was measured
- Incidence of antibiotic-associated diarrhea and adverse events
THE PAPER
Probiotics for the prevention of pediatric antibiotic-associated diarrhea.
Johnston BC, Supina AL, Ospina M, Vohra S. Cochrane Database Syst Rev, 2007.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.